GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Elicio Therapeutics, Inc. (ELTX) | 10/9/2026 4:07:41 PM | View | Proxy | SEC | Y 2025 | ||||||
| Elicio Therapeutics, Inc. (ELTX) | 8/13/2026 4:16:45 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $31,330,000 | EPS -$0.43 | ||
| Elicio Therapeutics, Inc. (ELTX) | 5/11/2026 4:23:01 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $22,689,000 | EPS -$0.65 | ||
| Elicio Therapeutics, Inc. (ELTX) | 5/11/2026 4:07:56 PM | View | Financials | Earnings | WIRE | 1Q 2026 | Assets $22,689,000 | EPS -$0.65 | Export Earnings Model | ||
| Elicio Therapeutics, Inc. (ELTX) | 4/30/2026 4:02:54 AM | Micro | View | Financials | 10-K/A | SEC | Y 2025 ending: 12/31/2025 | Assets $25,862,000 | EPS -$2.58 | ||
| Elicio Therapeutics, Inc. (ELTX) | 3/12/2026 4:35:08 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $25,862,000 | EPS -$2.58 | ||
| Elicio Therapeutics, Inc. (ELTX) | 3/12/2026 4:07:22 PM | View | Financials | Earnings | WIRE | Y 2025 | Assets $25,862,000 | EPS -$0.49 | Export Earnings Model | ||
| Elicio Therapeutics, Inc. (ELTX) | 11/13/2025 4:24:12 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $28,284,000 | EPS -$0.60 | ||
| Elicio Therapeutics, Inc. (ELTX) | 11/13/2025 4:03:06 PM | View | Financials | Earnings | WIRE | 3Q 2025 | Assets $28,284,000 | EPS -$0.60 | Export Earnings Model | ||
| Elicio Therapeutics, Inc. (ELTX) | 8/7/2025 5:01:47 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $29,528,000 | EPS -$0.66 | ||
| Elicio Therapeutics, Inc. (ELTX) | 8/7/2025 4:30:55 PM | View | Financials | Earnings | WIRE | 2Q 2025 | Assets $29,528,000 | EPS -$0.66 | Export Earnings Model | ||
| Elicio Therapeutics, Inc. (ELTX) | 5/13/2025 4:44:40 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $28,144,000 | EPS -$0.87 | ||
| Elicio Therapeutics, Inc. (ELTX) | 5/13/2025 4:07:37 PM | View | Financials | Earnings | WIRE | 1Q 2025 | Assets $28,144,000 | EPS -$0.87 | Export Earnings Model | ||
| Elicio Therapeutics, Inc. (ELTX) | 4/9/2025 4:28:48 PM | View | Proxy | SEC | Y 2024 | ||||||
| Elicio Therapeutics, Inc. (ELTX) | 3/31/2025 7:13:59 AM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $28,178,000 | EPS -$4.25 | ||
| Elicio Therapeutics, Inc. (ELTX) | 3/31/2025 7:02:37 AM | View | Financials | Earnings | WIRE | 1Q 2025 | Assets $28,144,000 | EPS -$0.87 | Export Earnings Model | ||
| Elicio Therapeutics, Inc. (ELTX) | 11/13/2024 4:22:06 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $38,388,000 | EPS -$1.39 | ||
| Elicio Therapeutics, Inc. (ELTX) | 11/13/2024 4:07:12 PM | View | Financials | Earnings | WIRE | 3Q 2024 | Assets $38,388,000 | EPS -$1.39 | Export Earnings Model | ||
| Elicio Therapeutics, Inc. (ELTX) | 9/27/2024 4:41:46 PM | View | Proxy | SEC | Y 2023 | ||||||
| Elicio Therapeutics, Inc. (ELTX) | 8/13/2024 5:05:12 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $15,750,000 | EPS -$0.64 | ||
| Elicio Therapeutics, Inc. (ELTX) | 8/13/2024 4:32:11 PM | View | Financials | Earnings | WIRE | 2Q 2024 | Assets $15,750,000 | EPS -$0.64 | Export Earnings Model | ||
| Elicio Therapeutics, Inc. (ELTX) | 5/15/2024 4:58:48 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $24,480,000 | EPS -$1.15 | ||
| Elicio Therapeutics, Inc. (ELTX) | 5/15/2024 4:31:12 PM | View | Financials | Earnings | WIRE | 1Q 2024 | Assets $24,480,000 | EPS -$1.15 | Export Earnings Model | ||
| Elicio Therapeutics, Inc. (ELTX) | 4/29/2024 7:16:46 AM | Micro | View | Financials | 10-K/A | SEC | Y 2023 ending: 12/31/2023 | Assets $27,146,000 | EPS -$6.96 | ||
| Elicio Therapeutics, Inc. (ELTX) | 3/29/2024 2:21:40 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $27,146,000 | EPS -$6.96 | ||
| Elicio Therapeutics, Inc. (ELTX) | 3/29/2024 8:37:31 AM | View | Presentation | SEC | 1Q 2024 | ||||||
| Elicio Therapeutics, Inc. (ELTX) | 3/29/2024 8:31:40 AM | View | Financials | Earnings | WIRE | Y 2023 | Assets $27,146,000 | EPS -$3.77 | Export Earnings Model | ||
| Elicio Therapeutics, Inc. (ELTX) | 11/13/2023 9:05:25 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $30,987,000 | EPS -$1.27 | ||
| Elicio Therapeutics, Inc. (ELTX) | 11/9/2023 4:42:33 PM | View | Presentation | SEC | Y 2023 | ||||||
| Elicio Therapeutics, Inc. (ELTX) | 11/9/2023 4:31:57 PM | View | Financials | Earnings | WIRE | 3Q 2023 | Assets $30,987,000 | EPS -$1.27 | Export Earnings Model | ||
| Elicio Therapeutics, Inc. (ELTX) | 8/14/2023 6:15:17 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $37,619,000 | EPS -$2.61 | ||
| Elicio Therapeutics, Inc. (ELTX) | 8/11/2023 11:43:47 AM | View | Financials | Earnings | SEC | 2Q 2023 | Assets $37,619,000 | EPS -$2.61 | Export Earnings Model | ||
| Angion Biomedica Corp. (ELTX) | 5/10/2023 4:20:56 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $41,767,000 | EPS -$24.77 | ||
| Angion Biomedica Corp. (ELTX) | 4/28/2023 4:52:05 PM | Micro | View | Financials | 10-K/A | SEC | Y 2022 ending: 12/31/2022 | ||||
| Angion Biomedica Corp. (ELTX) | 3/17/2023 4:40:34 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | ||||
| Angion Biomedica Corp. (ELTX) | 11/14/2022 4:37:57 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $61,316,000 | EPS -$22.67 | ||
| Angion Biomedica Corp. (ELTX) | 8/15/2022 5:17:37 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $70,813,000 | EPS -$23.20 | ||
| Angion Biomedica Corp. (ELTX) | 8/15/2022 4:21:25 PM | View | Financials | Earnings | SEC | Y 2022 | Assets $22,664,000 | EPS -$20.75 | Export Earnings Model | ||
| Angion Biomedica Corp. (ELTX) | 6/29/2022 4:12:14 PM | View | Financials | Earnings (Prelim) | SEC | Y 2022 | Export Earnings Model | ||||
| Angion Biomedica Corp. (ELTX) | 5/16/2022 5:00:49 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $1,648,000 +344.2% | Assets $81,258,000 | EPS -$0.48 | |
| Angion Biomedica Corp. (ELTX) | 5/16/2022 4:24:10 PM | View | Financials | Earnings | SEC | Y 2022 | Assets $22,664,000 | EPS -$20.75 | Export Earnings Model | ||
| Angion Biomedica Corp. (ELTX) | 4/27/2022 4:12:27 PM | View | Proxy | SEC | Y 2021 | ||||||
| Angion Biomedica Corp. (ELTX) | 3/30/2022 5:17:38 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | ||||
| Angion Biomedica Corp. (ELTX) | 3/30/2022 4:54:40 PM | View | Financials | Earnings | SEC | Y 2022 | Assets $22,664,000 | EPS -$20.75 | Export Earnings Model | ||
| Angion Biomedica Corp. (ELTX) | 1/4/2022 4:50:10 PM | View | Financials | Earnings (Prelim) | SEC | Y 2022 | Export Earnings Model | ||||
| Angion Biomedica Corp. (ELTX) | 11/12/2021 7:15:13 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $1,460,000 +76.5% | Assets $109,940,000 | EPS -$0.53 | |
| Angion Biomedica Corp. (ELTX) | 11/12/2021 7:07:37 AM | View | Financials | Earnings | SEC | Y 2022 | Assets $22,664,000 | EPS -$20.75 | Export Earnings Model | ||
| Angion Biomedica Corp. (ELTX) | 10/26/2021 4:13:55 PM | View | Financials | Earnings (Prelim) | SEC | Y 2022 | Export Earnings Model | ||||
| Angion Biomedica Corp. (ELTX) | 8/12/2021 4:23:17 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $540,000 -25.9% | Assets $125,359,000 | EPS -$0.58 | |
| Angion Biomedica Corp. (ELTX) | 8/12/2021 4:18:34 PM | View | Financials | Earnings | SEC | Y 2022 | Assets $22,664,000 | EPS -$20.75 | Export Earnings Model | ||
| Angion Biomedica Corp. (ELTX) | 5/17/2021 6:41:57 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $371,000 -57.1% | Assets $139,200,000 | EPS -$1.56 | |
| Angion Biomedica Corp. (ELTX) | 5/17/2021 6:33:39 AM | View | Earnings | SEC | Y 2022 | Assets $22,664,000 | EPS -$20.75 | ||||
| Angion Biomedica Corp. (ELTX) | 3/30/2021 5:34:39 PM | View | Earnings | SEC | Y 2022 | Assets $22,664,000 | EPS -$20.75 |